Order Article Reprints

Tapadar S, Fathi S, Wu B, Sun CQ, Raji I, Moore SG, Arnold RS, Gaul DA, Petros JA, Oyelere AK. Liver-Targeting Class I Selective Histone Deacetylase Inhibitors Potently Suppress Hepatocellular Tumor Growth as Standalone Agents. Cancers. 2020; 12(11):3095. https://doi.org/10.3390/cancers12113095

Tapadar, Subhasish, Shaghayegh Fathi, Bocheng Wu, Carrie Q. Sun, Idris Raji, Samuel G. Moore, Rebecca S. Arnold, David A. Gaul, John A. Petros, and Adegboyega K. Oyelere. 2020. "Liver-Targeting Class I Selective Histone Deacetylase Inhibitors Potently Suppress Hepatocellular Tumor Growth as Standalone Agents" Cancers 12, no. 11: 3095. https://doi.org/10.3390/cancers12113095

Tapadar, S., Fathi, S., Wu, B., Sun, C. Q., Raji, I., Moore, S. G., Arnold, R. S., Gaul, D. A., Petros, J. A., & Oyelere, A. K. (2020). Liver-Targeting Class I Selective Histone Deacetylase Inhibitors Potently Suppress Hepatocellular Tumor Growth as Standalone Agents. Cancers, 12(11), 3095. https://doi.org/10.3390/cancers12113095